Special Delivery

Adenoviruses offer powerful gene delivery capabilities. The rising demands for genetically engineered products such as growth hormones and anticancer therapies keeps gene transfer technologies rapidly evolving. Gene transfer often exploits the power of viruses such as adenovirus to deliver genetic material into cells. The adenovirus system is particularly useful since the virus infects virtually any cell type, including mammalian cells. Quantum Biotechnologies Inc. of Montreal has made the adeno

Written byScott Ewan
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share


Adenoviruses offer powerful gene delivery capabilities.
The rising demands for genetically engineered products such as growth hormones and anticancer therapies keeps gene transfer technologies rapidly evolving. Gene transfer often exploits the power of viruses such as adenovirus to deliver genetic material into cells. The adenovirus system is particularly useful since the virus infects virtually any cell type, including mammalian cells. Quantum Biotechnologies Inc. of Montreal has made the adenovirus gene delivery system even more accessible to the researcher with the launch of the AdEasy system, a complete kit for recombinant adenovirus production. The new system takes advantage of technology developed by researchers at Johns Hopkins University and exploits recombination in bacteria instead of mammalian cells for easy manipulation, efficient recombination, and easy selection of the successful clones.1

To use the kit, the cDNA of interest is first cloned into a transfer vector before recombination into the adenovirus in Escherichia coli. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies